Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying Neurocognitive Outcomes and Cerebral Oxygenation in Critically Ill Adults on Acute Kidney Replacement Therapy in the Intensive Care Unit

NCT04722939 is registered in ClinicalTrials.gov with Dr. Gordon Boyd as lead sponsor.

NCT NCT04722939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04722939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying Neurocognitive Outcomes and Cerebral Oxygenation in Critically Ill Adults on Acute Kidney Replacement Therapy in the Intensive Care Unit
Lead sponsor
Dr. Gordon Boyd
Phase
Observational
Overall status
Recruiting
Start date
January 15, 2021
Completion date
January 1, 2027
Enrollment
104 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, cerebral autoregulation, cerebral oxygenation, cognitive impairment, critical illness, delirium